Literature DB >> 23169601

Muscle phenotype in patients with myotonic dystrophy type 1.

Grete Andersen1, Mette C Ørngreen, Nicolai Preisler, Eskild Colding-Jørgensen, Torben Clausen, Morten Duno, Tina D Jeppesen, John Vissing.   

Abstract

INTRODUCTION: The pathogenesis of muscle involvement in patients with myotonic dystrophy type 1 (DM1) is not well understood. In this study, we characterized the muscle phenotype in patients with confirmed DM1.
METHODS: In 38 patients, muscle strength was tested by hand-held dynamometry. Myotonia was evaluated by a handgrip test and by analyzing the decrement of the compound muscle action potential. Muscle biopsies were assessed for morphological changes and Na(+)-K(+) pump content.
RESULTS: Muscle strength correlated with a decline in Na(+)-K(+) pump content (r = 0.60, P < 0.001) and with CTG expansion. CTG expansion did not correlate with severity of myotonia, proximal histopathological changes, or Na(+)-K(+) pump content. Histopathologically, we found few centrally placed nuclei (range 0.2-6.9%).
CONCLUSIONS: The main findings of this study are that muscle weakness correlated inversely with CTG expansion and that central nuclei are not a prominent feature of proximal muscles in DM1.
Copyright © 2012 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169601     DOI: 10.1002/mus.23535

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.

Authors:  Gayle Overend; Cécilia Légaré; Jean Mathieu; Luigi Bouchard; Cynthia Gagnon; Darren G Monckton
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

2.  Unexpected dependence of RyR1 splice variant expression in human lower limb muscles on fiber-type composition.

Authors:  Hermia Willemse; Angelo Theodoratos; Paul N Smith; Angela F Dulhunty
Journal:  Pflugers Arch       Date:  2015-10-06       Impact factor: 3.657

3.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

4.  In vivo assessment of muscle membrane properties in myotonic dystrophy.

Authors:  S Veronica Tan; Werner J Z'graggen; Delphine Boërio; Christopher Turner; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2016-05-24       Impact factor: 3.217

5.  The Need for a Consensus on the Locution "Central Nuclei" in Striated Muscle Myopathies.

Authors:  Anna L Mazzotti; Dario Coletti
Journal:  Front Physiol       Date:  2016-11-23       Impact factor: 4.566

6.  Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1.

Authors:  Jean-Yves Hogrel; Gwenn Ollivier; Isabelle Ledoux; Luc J Hébert; Bruno Eymard; Jack Puymirat; Guillaume Bassez
Journal:  Ann Clin Transl Neurol       Date:  2017-11-07       Impact factor: 4.511

7.  Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.

Authors:  Linda Heskamp; Marlies van Nimwegen; Marieke J Ploegmakers; Guillaume Bassez; Jean-Francois Deux; Sarah A Cumming; Darren G Monckton; Baziel G M van Engelen; Arend Heerschap
Journal:  Neurology       Date:  2019-05-22       Impact factor: 9.910

8.  Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1.

Authors:  Kazuma Sugie; Miho Sugie; Toshio Taoka; Yasuyo Tonomura; Aya Kumazawa; Tesseki Izumi; Kimihiko Kichikawa; Satoshi Ueno
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

Review 9.  Core Clinical Phenotypes in Myotonic Dystrophies.

Authors:  Stephan Wenninger; Federica Montagnese; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

10.  Responsiveness of outcome measures in myotonic dystrophy type 1.

Authors:  Kirsten L Knak; Aisha M Sheikh; Nanna Witting; John Vissing
Journal:  Ann Clin Transl Neurol       Date:  2020-07-16       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.